...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: no bids or asks on the TD plat this morn?? - anyone seeing anything?

a halt would be most welcome, i think

Share
New Message
Please login to post a reply